Pharmalink

Name

Pharmalink

Legal name

Pharmalink

Website

https://pharmalink.ae

Company type

Private

Founded year

1993

Operating status

Operating

Headcount range

501–1,000 employees

Ownership category

akta.pro rank

Product category

Pharmaceutical Distribution Services

NAICS

Drugs and Druggists' Sundries Merchant Wholesalers (424210), Drugs and Druggists' Sundries Merchant Wholesalers (42421), Pharmacies and Drug Retailers (456110)

SIC

Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122), Retail-Drug Stores And Proprietary Stores (5912)

akta.pro primary industry

Specialty Pharmaceutical Distributors (HLAIAJAB)

akta.pro secondary industries

Retail & Community Pharmacies (Chain/Independent) (HLAFALAA), Specialty Pharma & Biologics Distribution (GDP-compliant) (HLAGAMAD)

Keywords

• Pharmaceutical distribution
• Pharmaceutical commercialization
• Retail pharmacy chain
• Pharmaceutical logistics
• Regulatory affairs services

Headquarters

HQ city

Abu Dhabi

HQ country

United Arab Emirates

HQ region

Middle East

Offices4 records

Markets served

GTM type

B2B and B2C

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Supply Chain, Infrastructure, Technology or R&D

Revenue model

1. Pharmaceutical Distribution and Commercialization: Pharmalink receives pharmaceutical products from partner companies at pre-determined prices and distributes/commercializes them across UAE and GCC markets. The company handles local sales, promotion, and distribution while partners retain marketing authorizations and supply finished products.
2. Retail Pharmacy Operations (MEDICINA): Operation of MEDICINA chain of pharmacies, providing healthcare products and services directly to consumers through retail storefronts across the UAE.
3. Nutraceutical Product Distribution: Exclusive distribution of nutraceutical products (Sky Premium Life) in UAE market through purchase orders, with cumulative orders reaching 270,000 units since partnership began in June 2024.

Go-to-market motion3 records

Distribution channels4 records

Marketing channels5 records

Core offering

Pharmalink is a fully integrated pharmaceutical distribution and commercialization organization that supplies life-saving and emergency drugs across the UAE and GCC region. It serves as the exclusive local distributor for more than 70 international pharmaceutical partners, handling regulatory registration, sales, marketing, warehousing, logistics and last-mile delivery, while also operating the MEDICINA chain of more than 130 retail pharmacies that serves end consumers directly.

Product overview

Pharmalink is a fully integrated one-stop-shop healthcare organization operating across the GCC region. The company offers a diversified portfolio of cutting-edge healthcare solutions spanning therapeutic areas including Lifestyle & Well Being, Gastroenterology, Respiratory, Oncology, Pain Care, Therapeutic Skin Care, Dental Care, Women's Health Care, Anti-Infectives, CNS, Cardiovascular, Men's Health Care, Anaesthesia, Critical Care, Rare Diseases, Ophthalmology, and Radiology. Its core offerings include the MEDICINA retail pharmacy chain, pharmaceutical distribution and commercialization services, regulatory affairs support, and logistics/supply chain solutions. The company distributes branded pharmaceutical products like Quviviq for insomnia and nutraceutical brands including Sky Premium Life, serving as the exclusive UAE distributor for multiple international healthcare partners.

Differentiator

Problem solved

Functional benefit

Brands

• Medicina: Retail pharmacy chain operated by Pharmalink, developed since 2013 with contemporary state-of-the-art architecture, offering more than 130 pharmacies across the 7 emirates of the UAE.

Products and services

• MEDICINA Chain of Pharmacies Owned retail pharmacy chain with more than 130 stores across the 7 UAE emirates serving patients and consumers with state-of-the-art pharmacy architecture, professional pharmacist services, and access to a curated portfolio of pharmaceutical, wellness and nutraceutical products.
• Sky Premium Life Nutraceutical Distribution Exclusive distribution in the UAE of the Sky Premium Life nutraceutical brand owned by Cosmos Health Inc., sold into Pharmalink's network of more than 3,000 pharmacies including the MEDICINA chain. Cumulative orders reached 270,000 units since partnership inception with a target of 3 million cumulative units over the first five years.
• Quviviq (daridorexant) Pharmaceutical Distribution Exclusive distribution and commercialization in GCC countries (UAE, Kuwait, Qatar, Oman, Bahrain) of Quviviq, a prescription insomnia therapy marketed globally by Idorsia. Pharmalink handles local sales, promotion, regulatory execution and distribution while Idorsia retains marketing authorizations and supplies the finished product.
• Sales & Marketing Services Fully inclusive sales and marketing service from market sensing to widespread commercialization across the GCC region, featuring a medical sales force of professional medico-marketing representatives engaging healthcare professionals, pharmacists and key stakeholders, supported by analytics, forecasting, and innovative multichannel marketing strategies.
• Logistics, Supply and Distribution Pharmaceutical warehousing and last-mile distribution service using SAP EWM automated warehouses in Abu Dhabi and Dubai and an owned fleet of more than 30 trucks and vans, ensuring medicines reach customers in proper condition across all 7 UAE emirates.
• Regulatory Affairs & Pharmacovigilance Regulatory affairs service for product registration and lifecycle management across the UAE and GCC, including a dedicated pharmacovigilance officer for patient safety monitoring and staff training on the latest pharmacovigilance updates, designed to help international partners fast-track market entry.

Quantifiable outcome

• Reach 95% of UAE market through sales force coverage
• +2 more outcomes

Named customers2 records

Segments4 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability3 records

Feature4 records

Partnerships

Three partnerships are on record, tiered core.

• IdorsiacoreChannel Partner/ Reseller/ Distributor · 11 March 2026Idorsia has signed an exclusive agreement with Pharmalink Drug Store to distribute and commercialize Quviviq (daridorexant) insomnia therapy in Kuwait, Oman, Qatar, Bahrain, and UAE. Under the deal, Idorsia retains marketing authorizations in each country and supplies the finished product at a pre-determined price, while Pharmalink handles local sales, promotion, and distribution. Quviviq is a dual orexin receptor antagonist already marketed in Europe, US, Canada, China, Hong Kong, Japan, and Latin America.
• Cosmos Health Inc.coreChannel Partner/ Reseller/ Distributor · 1 June 2024Pharmalink serves as exclusive distributor in the UAE for Cosmos Health's Sky Premium Life nutraceutical products. Cumulative orders reached 270,000 units since partnership began in June 2024, with Pharmalink aiming to reach 3 million cumulative units ordered over the first five years of the partnership. The distributor operates in UAE healthcare sector with access to over 3,000 pharmacies including its MEDICINA chain of around 200 locations.
• Multiple Pharmaceutical Partners (70+ international companies)coreChannel Partner/ Reseller/ DistributorPharmalink has established partnerships with over 70 international pharmaceutical companies from countries including Australia, Austria, Canada, Croatia, Denmark, France, Germany, Italy, Switzerland, United Kingdom, United States, and others. Partners include major pharmaceutical companies such as Mylan, Recordati, Roche, and others across therapeutic areas including gastroenterology, oncology, respiratory, cardiovascular, CNS, and more.

Scale indicators9 records

Recent moves5 records

Expansion highlights6 records

Broad incumbents

• Neopharma: UAE-based pharmaceutical manufacturer with broad generic and branded portfolio across the GCC, operating in both manufacturing and distribution — a comparable regional player across therapeutic categories served by Pharmalink.
• Gulf Pharmaceutical Industries (Julphar): One of the largest pharmaceutical manufacturers in the Middle East, headquartered in UAE, with manufacturing, distribution and regional brand presence that overlaps with Pharmalink's GCC commercialization activities.
• Hikma Pharmaceuticals: MENA-headquartered global pharmaceutical company with branded, generic and injectable businesses; a comparable scale player in the same regional markets where Pharmalink distributes and commercializes.

Regional players

• Tamer Group: Saudi-based healthcare group with pharmaceutical distribution, manufacturing and retail pharmacy operations; a directly comparable vertically integrated pharma distribution and retail business in the GCC.
• Life Pharma: UAE-based pharmaceutical distribution and marketing company operating across the MENA region with exclusive distribution agreements for international brands; a comparable regional pharma distribution and commercialization partner.
• Tabuk Pharmaceuticals: Saudi-headquartered pharmaceutical manufacturer with branded generics across MENA; comparable as a regional pharma player whose products are often distributed through partners like Pharmalink in GCC markets.
• SPIMACO (Saudi Pharmaceutical Industries & Medical Appliances Corp.): Leading Saudi-based pharmaceutical manufacturer and distributor; comparable as a GCC pharma player covering similar therapeutic areas and distribution channels that Pharmalink accesses.

Direct peers

• Al Ittihad Drug Store (IDS): UAE-based pharmaceutical distributor and wholesaler with a broad portfolio across branded and generic products. Closest direct peer to Pharmalink in pharmaceutical distribution, retail pharmacy and UAE market access.
• Yiaco Medical Company: Kuwait-based pharmaceutical and medical supplies distributor serving the GCC, including multi-country exclusive distribution agreements; directly comparable as a regional pharma distribution partner.
• ASTER Pharmacy (ASTER DM Healthcare): Large UAE and GCC retail pharmacy chain with broad pharmacy network; directly comparable to Pharmalink's MEDICINA retail pharmacy footprint and consumer-facing model.

Market position

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• Facebookfacebook.com/pharmalinkdrugstore1993
• LinkedInlinkedin.com/company/5032998
• Instagraminstagram.com/medicinapharmacies

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles7 records

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Pharmalink